scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(86)91298-5 |
P8608 | Fatcat ID | release_xk4ilj4euvbxxmauvpsjfpetsq |
P698 | PubMed publication ID | 2871307 |
P2093 | author name string | M Matsumoto | |
M Osame | |||
S Izumo | |||
K Usuku | |||
A Igata | |||
M Tara | |||
N Ijichi | |||
H Amitani | |||
P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells | Q34253011 | ||
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis | Q39021217 | ||
The basis of intra-blood-brain-barrier IgG synthesis. | Q48554203 | ||
P433 | issue | 8488 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Human T-lymphotropic virus 1 | Q1280388 |
P304 | page(s) | 1031-1032 | |
P577 | publication date | 1986-05-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | HTLV-I associated myelopathy, a new clinical entity. | |
P478 | volume | 1 |
Q63384202 | 40 years of the human T-cell leukemia virus: past, present, and future |
Q34145207 | 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo |
Q39577314 | 71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1. |
Q39418057 | A C77G point mutation in CD45 exon 4, which is associated with the development of multiple sclerosis and increased susceptibility to HIV-1 infection, is undetectable in Japanese population |
Q36645522 | A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I. |
Q43638796 | A case of classical mycosis fungoides associated with human T-cell lymphotropic virus type I. |
Q36666226 | A case of peripheral T-cell lymphoma, not otherwise specified in a HCV and HTLV-II-positive patient, diagnosed by abdominal fluid cytology |
Q34339734 | A case of post-transplant adult T-cell leukemia/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy |
Q36824252 | A cis element required for induction of the interleukin 2 enhancer by human T-cell leukemia virus type I binds a novel Tax-inducible nuclear protein |
Q55239322 | A clinical survey of uveitis in HTLV-1 endemic region. |
Q40874914 | A human B-lineage dendritic cell line, HBM-noda and its potential role in human T-cell leukemia/lymphoma virus type I infection |
Q38992578 | A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases |
Q40408082 | A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells |
Q41652462 | A novel alternatively spliced viral mRNA transcribed in cells infected with human T cell leukemia virus type 1 is mainly responsible for expressing p21X protein |
Q40582337 | A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design |
Q34353702 | A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76(gag-pro) defines the N terminus of RT. |
Q39305535 | A possible association between HLA and HTLV-I-associated myelopathy (HAM) in Japanese |
Q30485688 | A public HTLV-1 molecular epidemiology database for sequence management and data mining |
Q39106672 | A rat model for human T lymphocyte virus type I-associated myeloneuropathy. down-regulation of bcl-2 expression and increase in sensitivity to TNF-alpha of the spinal oligodendrocytes |
Q41397919 | A rat model of HTLV-I infection: development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis |
Q36231807 | A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats |
Q35533869 | A reduction of viral mRNA, proteins and induction of altered morphogenesis reveals the anti-HTLV-1 activity of the labdane-diterpene myriadenolide in vitro |
Q55241678 | A seroepidemiological survey of antibodies to HTLV-I/HTLV-II in selected population groups in Paraguay |
Q30425683 | A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system |
Q41666767 | ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity |
Q41246450 | ATL and HTLV-I: in vivo cell growth of ATL cells |
Q36361378 | Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers |
Q69903563 | Abnormal peripheral lymphocytes in tropical spastic paraparesis |
Q39541639 | Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy |
Q33490596 | Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder |
Q39255855 | Absence of HTLV-II Co-infection in HTLV-I-associated Myelopathy Patients |
Q36842571 | Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status |
Q37071800 | Acetylation at lysine 346 controls the transforming activity of the HTLV-1 Tax oncoprotein in the Rat-1 fibroblast model |
Q34283189 | Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template |
Q33709523 | Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway |
Q40399507 | Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells |
Q36964053 | Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model |
Q40497666 | Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors |
Q94539493 | Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells |
Q40407844 | Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression |
Q33785951 | Activation of human T-cell leukemia virus type 1 tax gene expression in chronically infected T cells |
Q39703814 | Activation of the PI3K-Akt pathway by human T cell leukemia virus type 1 (HTLV-1) oncoprotein Tax increases Bcl3 expression, which is associated with enhanced growth of HTLV-1-infected T cells |
Q36315843 | Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1. |
Q36652164 | Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor. |
Q35224934 | Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections |
Q39611012 | Adult T cell leukaemia-lymphoma |
Q55241690 | Adult T cell leukemia/lymphoma. Perspectives on the treatment. |
Q60916408 | Adult T-Cell Leukemia/Lymphoma-Related Ocular Manifestations: Analysis of the First Large-Scale Nationwide Survey |
Q72663098 | Adult T-cell leukaemia-lymphoma in Waldeyer's ring: a report of three cases |
Q44635224 | Adult T-cell leukemia/lymphoma in Jujuy, north-west Argentina |
Q55239437 | Adult T-cell leukemia/lymphoma in a 21-year-old man. |
Q35782912 | Adult T-cell leukemia: future prophylaxis and immunotherapy |
Q48737243 | Adult T-cell lymphoma involving the leptomeninges associated with a spinal cord schwannoma. |
Q35674201 | Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry |
Q39498023 | Age-dependent paraparesis in WKA rats: evaluation of MHC k-haplotype and HTLV-1 infection |
Q39088537 | Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation. |
Q33823227 | Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies |
Q39292518 | Amplification of HTLV-1-related sequences among patients with neurological disorders in highly endemic Nagasaki: lack of evidence for association of HTLV-1 with multiple sclerosis |
Q39012004 | Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients |
Q35608968 | An Evaluation of the Spontaneous Proliferation of Peripheral Blood Mononuclear Cells in HTLV-1-Infected Individuals Using Flow Cytometry |
Q38865288 | An autopsy case of human T-lymphotropic virus type I-associated myelopathy |
Q45435710 | Analysis of HLA class I and class II gene polymorphisms in Japanese patients with human T-cell lymphotropic virus type 1-associated uveitis |
Q38714221 | Analysis of HTLV-1 proviral load (PVL) and antibody detected with various kinds of tests in Japanese blood donors to understand the relationship between PVL and antibody level and to gain insights toward better antibody testing |
Q45025853 | Analysis of factors of relevance to rapid clinical progression in HTLV-I-associated myelopathy |
Q30621111 | Analysis of human T-cell leukemia virus type 1 particles by using cryo-electron tomography |
Q27621035 | Anchoring an extended HTLV-1 Rex peptide within an RNA major groove containing junctional base triples |
Q38050763 | Animal models on HTLV-1 and related viruses: what did we learn? |
Q36967203 | Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). |
Q39594158 | Anti-Rex aptamers as mimics of the Rex-binding element. |
Q45846668 | Antibodies against p40tax gene product of human T-lymphotropic virus type-I (HTLV-I) under various conditions of HTLV-I infection |
Q44701780 | Antibodies against retroviral core proteins in relation to disease outcome in patients with mycosis fungoides |
Q36831871 | Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people |
Q55236780 | Antibody to HTLV-I in indigenous inhabitants of the Andes and Amazon regions in Colombia. |
Q45856065 | Antibody to human T-lymphotropic virus in a patient with Guillain-Barré syndrome (case report) |
Q39300934 | Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis |
Q36056547 | Application of targeted enrichment to next-generation sequencing of retroviruses integrated into the host human genome |
Q28727305 | Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy |
Q40884401 | Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review |
Q33562978 | Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier |
Q64912641 | Association Between HTLV-1 Genotypes and Risk of HAM/TSP. |
Q39504852 | Association between HLA Class I Alleles and Proviral Load in HTLV-I Associated Myelopathy/Tropical Spastic Paraperesis (HAM/TSP) Patients in Iranian Population |
Q35123084 | Association between HLA-DQB1 alleles and HAM/TSP patients in Khorasan Province |
Q39206746 | Association of CD40 ligand expression on HTLV-I-infected T cells and maturation of dendritic cells |
Q39481239 | Association of Tuberculosis Status with Neurologic Disease and Immune Response in HTLV-1 Infection. |
Q36548660 | Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells |
Q39560951 | Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis |
Q38301372 | Autoantigen Ku protein is involved in DNA binding proteins which recognize the U5 repressive element of human T-cell leukemia virus type I long terminal repeat |
Q39255881 | Autonomous proliferation of HTLV-CD4+ T cell clones derived from human T cell leukemia virus type I (HTLV-I)-associated myelopathy patients |
Q39153041 | Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations |
Q92483504 | Balance Impairments in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection |
Q35964522 | Barefoot Plantar Pressure Indicates Progressive Neurological Damage in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection |
Q34198903 | Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry |
Q26830903 | Blood-brain barrier and retroviral infections |
Q80454564 | Bone marrow cells carrying the env-pX transgene play a role in the severity but not prolongation of arthritis in human T-cell leukaemia virus type-I transgenic rats: a possible role of articular tissues carrying the transgene in the prolongation of |
Q45834139 | Bone marrow derived cells express human T-cell lymphotropic virus type I (HTLV-I)-related antigens in patients with multiple sclerosis |
Q35000087 | Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo |
Q37670477 | Brain Metabolism Changes in Patients Infected with HTLV-1 |
Q35537421 | Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers |
Q42490427 | CCAAT/enhancer-binding proteins modulate human T cell leukemia virus type 1 long terminal repeat activation |
Q34667760 | CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP |
Q45362335 | Can thymic epithelial cells be infected by human T-lymphotropic virus type 1? |
Q33388659 | Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread |
Q37945242 | Cell surface markers in HTLV-1 pathogenesis |
Q40831727 | Cell type-specific E2F activation and cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. |
Q40714477 | Cell-free human T-cell leukemia virus type 1 binds to, and efficiently enters mouse cells |
Q36049779 | Cellular Factors Involved in HTLV-1 Entry and Pathogenicit |
Q39173052 | Cellular and humoral immune responses associated with HTLV-I associated myelopathy/tropical spastic paraparesis |
Q39013567 | Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) |
Q90400891 | Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis |
Q48960065 | Chapter 47: history of clinical neurology in Japan. |
Q35833900 | Characteristics of Adult T-Cell Leukemia/Lymphoma Patients with Long Survival: Prognostic Significance of Skin Lesions and Possible Beneficial Role of Valproic Acid |
Q39092412 | Characterization of T cells transmigrating through human endothelial cells in patients with HTLV-I-associated myelopathy. |
Q44798682 | Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein |
Q35837041 | Characterization of an infectious molecular clone of human T-cell leukemia virus type I. |
Q33590318 | Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection. |
Q39097191 | Characterization of two human lymphoid cell lines producing human T-lymphotropic virus type I (HTLV-I) isolated from patients with HTLV-I-associated myelopathy or encephalopathy |
Q55027437 | Chemiluminescence immunoassay to detect anti-HTLV-I antibodies. |
Q45743242 | Chemokine synthesis and cellular inflammatory changes in lungs of mice bearing p40tax of human T-lymphotropic virus type 1. |
Q39270237 | Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans |
Q38290883 | Chimeric proteins composed of Jun and CREB define domains required for interaction with the human T-cell leukemia virus type 1 Tax protein. |
Q81773135 | Chronic graft-versus-host disease-like autoimmune disorders spontaneously occurred in rats with neonatal thymus atrophy |
Q33588882 | Chronic polyradiculoneuropathy associated with human T-cell lymphotropic virus type I infection |
Q68338832 | Chronic progressive myelopathy: its relation to the spinal progressive form of multiple sclerosis |
Q37107022 | Chronic transmural bronchiolitis: a non-specific lesion of small airways |
Q28484214 | Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis |
Q39098415 | Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease |
Q36422133 | Clinical Trials and Treatment of ATL. |
Q45776151 | Clinical and immunologic features of human T-cell lymphotropic virus type I uveitis. |
Q43777263 | Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis |
Q39457794 | Clinical and physiological significance of abnormally prolonged central motor conduction time in HAM/TSP. |
Q38905700 | Clinical evolution of tropical spastic paraparesis: The Tumaco experience |
Q39459002 | Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran |
Q40983529 | Clinical implication of the integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma |
Q41646096 | Clinical indications of multiple integrations of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma |
Q36994979 | Clinical manifestations associated with HTLV type I infection: a cross-sectional study |
Q21131133 | Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis |
Q55240045 | Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers. |
Q92554749 | Clinical trial of a humanized anti-IL-2/IL-15 receptor β chain in HAM/TSP |
Q45434328 | Clinicopathological and virological analyses of familial human T-lymphotropic virus type I--associated polyneuropathy |
Q34156338 | Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients |
Q44532039 | Cloning and expression of the transmembranic glycoprotein from human T cell lymphotropic virus in a prokaryotic system |
Q24309545 | Cloning of novel isoforms of the human Gli2 oncogene and their activities to enhance tax-dependent transcription of the human T-cell leukemia virus type 1 genome |
Q34466396 | Co-dependence of HTLV-1 p12 and p8 functions in virus persistence |
Q39319460 | Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection. |
Q35101485 | Coactivator-associated arginine methyltransferase 1 enhances transcriptional activity of the human T-cell lymphotropic virus type 1 long terminal repeat through direct interaction with Tax. |
Q41707235 | Coexistence of Fusion Receptors for Human T-Cell Leukemia Virus Type-I (HTLV-I) and Human Immunodeficiency Virus Type-1 (HIV-1) on MOLT-4 Cells |
Q55239264 | Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients. |
Q37700567 | Combined cytolytic effects of a vaccinia virus encoding a single chain trimer of MHC-I with a Tax-epitope and Tax-specific CTLs on HTLV-I-infected cells in a rat model. |
Q55239039 | Complete Sequences of the Human T-Cell Leukemia Virus Type 1 Proviral Genomes from Newly Established Adult T-Cell Leukemia Cell Lines in Oita Prefecture, Japan. |
Q36560393 | Complex formation between CREB and Tax enhances the binding affinity of CREB for the human T-cell leukemia virus type 1 21-base-pair repeats |
Q55026249 | Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation. |
Q44620586 | Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II |
Q89509154 | Conservation of a Neutralization Epitope of Human T-cell Leukemia Virus Type 1 (HTLV-1) among Currently Endemic Clinical Isolates in Okinawa, Japan |
Q35763367 | Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells |
Q39580554 | Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene |
Q39269105 | Constitutive expression of the cyclooxygenase-2 gene in T-cell lines infected with human T cell leukemia virus type I. |
Q26852683 | Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects? |
Q35780796 | Correlation between LTR point mutations and proviral load levels among human T cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers |
Q34342472 | Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model |
Q35862019 | Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax. |
Q97067407 | Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis |
Q39167266 | Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease |
Q27617901 | Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins |
Q38634316 | Current concepts about multiple sclerosis |
Q50520637 | Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. |
Q37198681 | Current topics in prevention of human T-cell leukemia virus type i infection: NF-kappa B inhibitors and APOBEC3. |
Q39452117 | Cutaneous and neurologic disease associated with HTLV-I infection |
Q41170711 | Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I. |
Q36251464 | Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). |
Q33910622 | DC-SIGN (CD209) gene promoter polymorphisms in a Brazilian population and their association with human T-cell lymphotropic virus type 1 infection |
Q40287235 | DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells |
Q40541784 | DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations |
Q38983203 | DNA sequence analysis of the gene encoding the HTLV-I P21E transmembrane protein reveals inter- and intraisolate genetic heterogeneity |
Q39292402 | De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice |
Q44718738 | Defective human T-lymphotropic virus type 1 provirus in asymptomatic carriers |
Q42050696 | Degeneration of oxidative muscle fibers in HTLV-1 tax transgenic mice |
Q34157297 | Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice |
Q37672616 | Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I). |
Q36103218 | Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR. |
Q35765050 | Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma |
Q33256730 | Detection of HTLV-I and -II in Scottish blood donor samples and archive donations |
Q36363731 | Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis |
Q45758441 | Detection of human T lymphotropic virus type I proviral DNA in patients with diffuse panbronchiolitis |
Q38928344 | Detection of human T-cell lymphotropic virus type 1 in plasma samples. |
Q35259821 | Detection of human retroviruses by PCR |
Q33850951 | Detection of provirus in an HTLV-II producer CD8+ T cell line by polymerase chain reaction combined with digoxigenin-ELISA method |
Q41397145 | Detection of the cellular membrane proteins on human T cell leukemia virus type I. |
Q39528053 | Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections |
Q39150767 | Development of [Ile⁴⁰]HTLV-I protease inhibition assay using novel fluorogenic and chromogenic substrate |
Q41630418 | Development of a supersensitive polymerase chain reaction method for human T lymphotropic virus type II (HTLV-II) and detection of HTLV-II proviral DNA from blood donors in Japan |
Q37171376 | Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1). |
Q69241776 | Diagnosis of multiple sclerosis |
Q39092457 | Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals |
Q40451275 | Differential activation of the 21-base-pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP. |
Q39139884 | Differential diagnosis of HTLV-I-associated myelopathy and multiple sclerosis in Iranian patients |
Q37691270 | Differential diagnosis of white matter diseases in the tropics: An overview |
Q46613891 | Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma |
Q37191904 | Dimerization and a novel Tax speckled structure localization signal are required for Tax nuclear localization |
Q36498251 | Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients |
Q39010923 | Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP). |
Q39010929 | Disability profile of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis using the Functional Independence Measure (FIM). |
Q34450086 | Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis |
Q39171333 | Discrepancy, coincidence or evidence in chronic idiopathic spastic paraparesis throughout the world. A meta-analysis on 2811 patients |
Q36947017 | Distinct Morphology of Human T-Cell Leukemia Virus Type 1-Like Particles. |
Q58765362 | Distinct Pathway of Human T-Cell Leukemia Virus Type 1 Gag Punctum Biogenesis Provides New Insights into Enveloped Virus Assembly |
Q37657776 | Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis |
Q58608708 | Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP |
Q33605874 | Distinct p300-responsive mechanisms promote caspase-dependent apoptosis by human T-cell lymphotropic virus type 1 Tax protein |
Q35826764 | Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion |
Q39139873 | Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. |
Q39141890 | Do human T-lymphotrophic viruses (HTLVs) and other enveloped viruses induce autoimmunity in multiple sclerosis? |
Q40044710 | Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. |
Q40066482 | Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance |
Q37827194 | Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity |
Q37337951 | Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways. |
Q38867016 | Dysautonomia in human T-cell lymphotrophic virus type I-associated myelopathy/tropical spastic paraparesis |
Q36713538 | Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease |
Q92128584 | EOS, an Ikaros family zinc finger transcription factor, interacts with the HTLV-1 oncoprotein Tax and is downregulated in peripheral blood mononuclear cells of HTLV-1-infected individuals, irrespective of clinical statuses |
Q35989638 | Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy. |
Q35663886 | Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals |
Q33825371 | Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy |
Q34113074 | Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro |
Q38768079 | Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study |
Q36689405 | Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1 |
Q39311297 | Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis |
Q40784053 | Efficacy of 3'-azido 3'deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells. |
Q55239076 | Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus-1 associated myelopathy. |
Q34941384 | Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial |
Q39412421 | Efficient transfer of HTLV-1 tax gene in various primary and immortalized cells using a flap lentiviral vector |
Q39688951 | Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1. |
Q39014388 | Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy |
Q39558557 | Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases |
Q35857603 | Enhanced replication of human T-cell leukemia virus type 1 in T cells from transgenic rats expressing human CRM1 that is regulated in a natural manner |
Q55240469 | Enhancement of nucleocytoplasmic export of HTLV-1 Rex mRNA through cis and trans interactions of the mRNA with the complex of Rex protein and Rex-responsive element. |
Q35826330 | Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures |
Q55242078 | Epidemiologic assessment of screening tests for antibody to human T lymphotropic virus type I (HTLV-I). |
Q28534288 | Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central China |
Q40041843 | Epidemiological and clinical features of adult T-cell leukemia-lymphoma (ATL) in Japan, 2010-2011: a nationwide survey |
Q30371156 | Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs. |
Q38934609 | Erectile dysfunction and HTLV-I infection: a silent problem |
Q91967430 | Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice |
Q33816840 | Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax. |
Q40991139 | Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1. |
Q54736313 | Evaluation of HTLV-I removal by filtration of blood cell components in a routine setting. |
Q36794828 | Evaluation of commercial HTLV-1 test kits by a standard HTLV-1 serum panel. |
Q52480067 | Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II |
Q45846671 | Evaluation of the human T-cell leukemia virus type I seropositivity of blood donors by the particle agglutination inhibition test |
Q55240554 | Evidence of HTLV-I in thyroid tissue in an HTLV-I carrier with Hashimoto's thyroiditis. |
Q92478942 | Evidence of New Endemic Clusters of Human T-Cell Leukemia Virus (HTLV) Infection in Bahia, Brazil |
Q50930958 | Evidence of a higher prevalence of HPV infection in HTLV-1-infected women: a cross-sectional study. |
Q33933778 | Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea |
Q35891748 | Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide |
Q24803711 | Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers |
Q33854237 | Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors |
Q34150778 | Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein |
Q34587031 | Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. |
Q34756170 | Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response |
Q38954009 | Experimental HTLV-I infection and associated myelopathy |
Q41500975 | Exposure of p19 matrix protein of human T-cell leukemia virus type I (HTLV-I) on the surface of MOLT-4#8 cells after virus adsorption |
Q39095798 | Expression and significance of Pim-3 kinase in adult T-cell leukemia. |
Q33707390 | Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion |
Q39067179 | Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals |
Q54205015 | Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1. |
Q55240032 | Expression, purification and biological properties of the carboxyl half part of the HTLV-I surface envelope glycoprotein. |
Q44385186 | Extraordinary High Rate of HTLV Type II Seropositivity in Intravenous Drug Abusers in South Vietnam |
Q55239347 | Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area. |
Q39136776 | Failure in activation of the canonical NF-κB pathway by human T-cell leukemia virus type 1 Tax in non-hematopoietic cell lines |
Q33573817 | Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis |
Q34779059 | Familial transmission of human T-cell lymphotrophic virus: silent dissemination of an emerging but neglected infection |
Q55239042 | Fine-scale geographic clustering pattern of human T-cell leukemia virus type 1 infection among blood donors in Kyushu-Okinawa, Japan. |
Q42160153 | Forefront studies on HTLV-1 oncogenesis |
Q30991310 | Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein |
Q39014319 | Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). |
Q36694078 | Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis |
Q33944410 | Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B. |
Q40301664 | Functional analysis of human T lymphotropic virus type 2 Tax proteins |
Q40106375 | Functional analysis of human T-cell leukemia virus type I rex-response element: direct RNA binding of Rex protein correlates with in vivo activity |
Q40784058 | Functional changes in astrocytes by human T-lymphotropic virus type-1 T-lymphocytes |
Q33495989 | Functional interaction of HTLV-1 tax protein with the POZ domain of the transcriptional repressor BCL6. |
Q35984815 | Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo |
Q39605657 | GLI-2 modulates retroviral gene expression |
Q35635241 | GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1. |
Q35105616 | Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission |
Q41402428 | Gene expression of neurotropic retrovirus in the CNS. |
Q33713794 | Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients |
Q39381446 | Genetic characterization and phylogeny of human T-cell lymphotropic virus type I from Chile |
Q33655605 | Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I. |
Q33834966 | Genetic evidence of a role for ATM in functional interaction between human T-cell leukemia virus type 1 Tax and p53. |
Q39307467 | Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease |
Q34529971 | Genome editing and the next generation of antiviral therapy. |
Q41192007 | Geographic and molecular epidemiology of primate T lymphotropic retroviruses: HTLV-I, HTLV-II, STLV-I, STLV-PP, and PTLV-L. |
Q45852141 | Geographical distribution of subjects seropositive for human T-cell leukemia virus type 1 in Papua New Guinea |
Q36254899 | Global epidemiology of HTLV-I infection and associated diseases |
Q39124772 | Graves' disease in HTLV-I carriers |
Q36966593 | HAM/TSP attributable to blood transfusion |
Q36452983 | HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy |
Q36379492 | HLA class II disease associations in southern Africa |
Q55239505 | HPRT mutations, TCR gene rearrangements, and HTLV-1 integration sites define in vivo T-cell clonal lineages. |
Q33734795 | HTLV 1 associated myelopathy and adult T cell leukaemia-lymphoma in the same patient: report of a case |
Q64085048 | HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients |
Q89965417 | HTLV-1 Infection and Rheumatic Diseases |
Q33779850 | HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro |
Q21134702 | HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter |
Q37021560 | HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase |
Q37152235 | HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking. |
Q39172189 | HTLV-1 and myelopathy in Salvador (northeastern Brazil): a case control study |
Q39268748 | HTLV-1 and polymyositis in Jamaica |
Q39292062 | HTLV-1 associated myelopathy in an HTLV-1 and HBV double carrier family: report of a case and the mode of vertical transmission of both viruses |
Q35669209 | HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines |
Q34567317 | HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo |
Q34998237 | HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression |
Q92017170 | HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP |
Q92212791 | HTLV-1 infection of myeloid cells: from transmission to immune alterations |
Q34043666 | HTLV-1 infections |
Q39403898 | HTLV-1 infects human mesenchymal stromal cell in vitro and modifies their phenotypic characteristics |
Q36269748 | HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil |
Q36112549 | HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals |
Q55240878 | HTLV-1 oncoprotein Tax deregulates transcription of cellular genes through multiple mechanisms. |
Q54246956 | HTLV-1 proviral load in cerebrospinal fluid may not be a good marker to differentiate asymptomatic carriers with high proviral load in blood from HAM/TSP patients. |
Q39479028 | HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking |
Q31151159 | HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infection |
Q39614932 | HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors |
Q24607794 | HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications |
Q36111401 | HTLV-1 uveitis |
Q57825486 | HTLV-1, ATLL, severe hypercalcaemia and HIV-1 co-infection: an overview |
Q47562043 | HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment |
Q36279205 | HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene |
Q59354958 | HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-Lymphoma |
Q38060839 | HTLV-1-associated infective dermatitis: updates on the pathogenesis |
Q67665443 | HTLV-1-associated myelopathy (HAM) with OKT4 epitope deficiency |
Q45096240 | HTLV-1-associated myelopathy/tropical spastic paraparesis |
Q39153396 | HTLV-1-associated myelopathy/tropical spastic paraparesis-like rats by intravenous injection of HTLV-1-producing rabbit or human T-cell line into adult WKA rats |
Q36352523 | HTLV-1-infected T cells contain a single integrated provirus in natural infection |
Q59355916 | HTLV-1/2 prevalence in two Amazonian communities |
Q44902398 | HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up |
Q36298491 | HTLV-2 Tax immortalizes human CD4+ memory T lymphocytes by oncogenic activation and dysregulation of autophagy |
Q38964582 | HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil |
Q34599506 | HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated |
Q33567646 | HTLV-I associated arthritis: characteristics of an HTLV-I virus infected T cell line from synovial fluid. |
Q38934593 | HTLV-I associated myelopathy in Brazil: a preliminary report |
Q39370492 | HTLV-I associated myelopathy in patients from Brazil and Iran: neurological manifestations and cerebrospinal fluid findings |
Q39242059 | HTLV-I associated myelopathy in salvador (northeastern Brazil) |
Q39317795 | HTLV-I associated myelopathy: a case of viral-induced auto-immunity |
Q39020706 | HTLV-I associated sicca syndrome in Guadeloupe: lack of relation with a peculiar encoding sequence of surface envelope glycoprotein |
Q37316339 | HTLV-I associated uveitis in central Japan |
Q43699477 | HTLV-I carrier with unusual brain MR imaging findings |
Q54699187 | HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy. |
Q39611577 | HTLV-I from Iranian Mashhadi Jews in Israel is phylogenetically related to that of Japan, India, and South America rather than to that of Africa and Melanesia |
Q36958734 | HTLV-I infection and neurological disease in Rio de Janeiro |
Q43312366 | HTLV-I infection in French West Indies: a case-control study |
Q33648572 | HTLV-I infection in human disease |
Q45833275 | HTLV-I myelitis: isolation of virus, genomic analysis, and infection in neural cell cultures |
Q69367951 | HTLV-I positive spastic paraparesis in a temperate zone |
Q39149923 | HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals |
Q55081753 | HTLV-I uveitis: a distinct clinical entity caused by HTLV-I |
Q55242900 | HTLV-I, brain abnormalities on magnetic resonance imaging, and relation with multiple sclerosis. |
Q55243841 | HTLV-I, visna, and tropical spastic paraparesis. |
Q55242670 | HTLV-I-associated meningitis. |
Q34063870 | HTLV-I-associated myelopathy |
Q39014393 | HTLV-I-associated myelopathy associated with multi-organ inflammatory disease: a case report |
Q55240344 | HTLV-I-infected T cells activate autologous CD4+ T cells susceptible to HTLV-I infection in a costimulatory molecule-dependent fashion. |
Q43459274 | HTLV-II among Italian intravenous drug users and hemophiliacs. |
Q42574751 | HTLV-II infection in the Western United States |
Q46580842 | HTLV-Is in Argentina are phylogenetically similar to those of other South American countries, but different from HTLV-Is in Africa |
Q24312994 | HUB1, a novel Krüppel type zinc finger protein, represses the human T cell leukemia virus type I long terminal repeat-mediated expression |
Q35757329 | Helminthic infection and the risk of neurologic disease progression in HTLV-1 |
Q44701841 | Hematopoietic progenitor cells as possible origins of epithelial thymoma in a human T lymphocyte virus type I pX gene transgenic rat model |
Q39715394 | Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil |
Q55239907 | High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. |
Q30973354 | High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease |
Q45767249 | High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies |
Q37014310 | High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response |
Q36890075 | High frequency of virus-specific CD8+ T cells in the central nervous system of macaques chronically infected with simian immunodeficiency virus SIVmac251. |
Q40741437 | High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders |
Q36637030 | High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type 1-producing cells. |
Q55240500 | High occurrence of primary malignant neoplasms in patients with adult T-cell leukemia/lymphoma, their siblings, and their mothers. |
Q33578804 | High prevalence of arthropathy in HTLV-I carriers on a Japanese island |
Q35682787 | High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease |
Q37288904 | High prevalence of skin disorders among HTLV-1 infected individuals independent of clinical status |
Q33183253 | High variability of HTLV-I in a remote population of Gabon as compared to that of a similar population of French Guiana |
Q21131117 | Highlights on distinctive structural and functional properties of HTLV Tax proteins |
Q33318640 | Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells |
Q42452746 | Histopathological and immunohistochemical assessment of acquired ichthyosis in patients with human T-cell lymphotropic virus type I-associated myelopathy. |
Q38997386 | Home-based exercise program in TSP/HAM individuals: a feasibility and effectiveness study |
Q35516989 | Hospital admissions for human T-cell lymphotropic virus type-1 (HTLV-1) associated diseases in Dominica |
Q39139856 | Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101. |
Q36736791 | Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans |
Q35261245 | Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis |
Q39081259 | Human T cell leukaemia virus type 2 tax protein mediates CC-chemokine expression in peripheral blood mononuclear cells via the nuclear factor kappa B canonical pathway |
Q33992848 | Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells |
Q41881538 | Human T cell leukemia virus type 2 tax-mediated NF-κB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO. |
Q39047641 | Human T cell leukemia virus type I Tax activates CD40 gene expression via the NF-kappa B pathway |
Q45735789 | Human T cell leukemia virus type I Tax enhances IL-4 gene expression in T cells |
Q39097151 | Human T cell leukemia virus type I infection and chronic myelopathy |
Q35111367 | Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration |
Q39093706 | Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 alpha/CCL20 gene transcription via the NF-kappa B pathway |
Q33536189 | Human T cell leukemia virus type-I and rheumatoid arthritis |
Q39031445 | Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP. |
Q37182373 | Human T cell lymphotropic virus type 1 infection and early neurologic development: a pilot study of 48 children |
Q33588672 | Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa |
Q42942655 | Human T cell lymphotropic virus type I and cutaneous T cell leukemia/lymphoma |
Q34105919 | Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers |
Q37123327 | Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism |
Q37305002 | Human T lymphotropic virus type 1 uveitis |
Q37305220 | Human T lymphotropic virus type 1 uveitis after Graves' disease |
Q45748119 | Human T lymphotropic virus type I (HTLV-I) infection in neurological patients in Salvador, Bahia, Brazil |
Q39153673 | Human T lymphotropic virus type I associated myelopathy with pulmonary and cutaneous lesions |
Q39120168 | Human T lymphotropic virus-1 infection |
Q39531858 | Human T-Cell Lymphotrophic Virus in California's Injection Drug Users |
Q36552267 | Human T-Cell Lymphotropic Virus Type I and II in Transfusion Medicine |
Q35112026 | Human T-Cell Lymphotropic Virus Type I and Neurological Diseases |
Q37160107 | Human T-Lymphotropic Virus (HTLV) Type I in vivo Integration in Oral Keratinocytes |
Q59353305 | Human T-Lymphotropic Virus-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Associated With Sexual Dysfunction in Infected Women of Reproductive Age |
Q38256603 | Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma |
Q40475835 | Human T-cell leukaemia virus. |
Q35057537 | Human T-cell leukemia retrovirus-Tax protein is a repressor of nuclear receptor signaling |
Q36688419 | Human T-cell leukemia virus (HTLV) type II Rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type 1 Rev-responsive element |
Q34233092 | Human T-cell leukemia virus open reading frame II encodes a posttranscriptional repressor that is recruited at the level of transcription. |
Q35024063 | Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells |
Q35635372 | Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. |
Q24671809 | Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, etc. |
Q33777633 | Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases |
Q38288604 | Human T-cell leukemia virus type 1 Tax modulates interferon-alpha signal transduction through competitive usage of the coactivator CBP/p300. |
Q40581800 | Human T-cell leukemia virus type 1 Tax oncoprotein induces and interacts with a multi-PDZ domain protein, MAGI-3. |
Q36974745 | Human T-cell leukemia virus type 1 Tax relieves repression of proliferating cell nuclear antigen gene expression |
Q37644070 | Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosis |
Q40967217 | Human T-cell leukemia virus type 1 can infect a wide variety of cells in mice |
Q39578739 | Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes |
Q42619328 | Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity |
Q24805664 | Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL) |
Q41431590 | Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene |
Q41489682 | Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency |
Q36828828 | Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation |
Q40063976 | Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation |
Q39028120 | Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor |
Q39937243 | Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules |
Q39269100 | Human T-cell leukemia virus type I tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T-cells through nuclear factor-kappaB and c-AMP responsive element binding protein pathways |
Q36812848 | Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells |
Q36683008 | Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy |
Q45731173 | Human T-cell lymphotrophic virus infection in organ donors: a need to reassess policy? |
Q34012655 | Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage |
Q41097684 | Human T-cell lymphotropic virus type 1 can infect primary rat retinal glial cells and induce gene expression of inflammatory cytokines |
Q33999613 | Human T-cell lymphotropic virus type 1 tax among American blood donors |
Q24525274 | Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha |
Q39263618 | Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis |
Q59351127 | Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand |
Q37781457 | Human T-cell lymphotropic virus type I sequences detected by nested polymerase chain reactions are not associated with multiple sclerosis |
Q36990286 | Human T-cell lymphotropic virus, type 1 (HTLV-1)-associated myelopathy: MR findings |
Q33876219 | Human T-cell lymphotropic virus-I in Latin America |
Q42998030 | Human T-lymphotrophic virus type I nucleocapsid protein NCp15: structural study and stability of the N-terminal zinc-finger |
Q34610888 | Human T-lymphotropic virus 1: recent knowledge about an ancient infection |
Q35276727 | Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease |
Q35611766 | Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control |
Q38104766 | Human T-lymphotropic virus type 1 non-structural proteins: Requirements for latent infection |
Q33827304 | Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters |
Q35847599 | Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction |
Q36617341 | Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. |
Q33557951 | Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii |
Q39124606 | Human T-lymphotropic virus type I (HTLV-I)-specific CD8+ cells accumulate in the lungs of patients infected with HTLV-I with pulmonary involvement |
Q40848250 | Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent. |
Q39611006 | Human T-lymphotropic virus type I in Japan |
Q33661263 | Human T-lymphotropic virus type I infection |
Q33929845 | Human T-lymphotropic virus type I provirus and T-cell prolymphocytic leukemia |
Q45753518 | Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors |
Q27301309 | Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography |
Q41627464 | Human T‐Cell Leukemia Virus‐1‐positive Cell Line Established from a Patient with Small Cell Lung Cancer |
Q36575342 | Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods |
Q40426651 | Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation |
Q47391092 | Human phospholipid scramblase 1 interacts with and regulates transactivation of HTLV-1 Tax. |
Q55359316 | Human retrovirus promotes the plasticity of regulatory T cells into T helper type 1-like cells through the T-bet transcriptional activation in neuroinflammatory disease. |
Q40429916 | Human retroviruses in the second decade: A personal perspective |
Q38247882 | Human retroviruses: a common virology |
Q36646919 | Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals |
Q68235341 | Hypercalcemia and production of parathyroid hormon.e-like protein in adult T-cell leukemia-lymphoma |
Q40429356 | I-mfa domain proteins specifically interact with HTLV-1 Tax and repress its transactivating functions. |
Q55239413 | IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection. |
Q40041190 | IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways. |
Q31811740 | IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II. |
Q38297147 | IL-2 withdrawal induces HTLV-1 expression through p38 activation in ATL cell lines |
Q35856454 | Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides. |
Q45368177 | Identification of CD44 as a downstream target of noncanonical NF-κB pathway activated by human T-cell leukemia virus type 1-encoded Tax protein |
Q55154170 | Identification of HTLV-I sequence in cord blood mononuclear cells of neonates born to HTLV-I antigen/antibody-positive mothers by polymerase chain reaction. |
Q38339893 | Identification of a functional serum response element in the HTLV-I LTR. |
Q38342800 | Identification of an osteoclast transcription factor that binds to the human T cell leukemia virus type I-long terminal repeat enhancer element |
Q41549343 | Identification of novel singly spliced pX mRNA transcripts common to all human T-cell leukemia virus type 1-related retroviruses |
Q41402570 | Identification of phosphocholine-containing glycoglycerolipids purified from Mycoplasma fermentans-infected human helper T-cell culture as components of M. fermentans |
Q37541342 | Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides |
Q55242553 | Identity of HTLV-I-associated tropical spastic paraparesis and HTLV-I-associated myelopathy. |
Q45881272 | Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies |
Q35873798 | Imbalanced expression of glutamate-glutamine cycle enzymes induced by human T-cell lymphotropic virus type 1 Tax protein in cultivated astrocytes |
Q39594099 | Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone |
Q41404176 | Immune recognition of genetically diverse simian T-cell lymphotropic virus type I isolates |
Q33651831 | Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). |
Q36944303 | Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia |
Q44091851 | Immunologic response and proviral load in human T-lymphotropic virus type 1 infected individuals with erectile dysfunction |
Q39487416 | Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity |
Q39139566 | Immunological studies of HTLV-I associated myelopathy |
Q34157538 | Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis |
Q36422111 | Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives |
Q34203309 | Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production |
Q55039421 | Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases. |
Q38885843 | Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease |
Q35125077 | Impact of donor infections on outcome of orthotopic liver transplantation |
Q92787350 | Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL |
Q46606105 | Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2. |
Q39481246 | Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid |
Q36944299 | Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia |
Q37247983 | Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay |
Q38900247 | In situ hybridization detection of HTLV-I RNA in peripheral blood mononuclear cells of TSP/HAM patients and their spouses |
Q35871154 | In vitro CD4+ lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotrophic virus type 1 |
Q55240633 | In vitro effects of immunosuppressive agents on cytokine production by HTLV-I-infected T cell clones derived from the ocular fluid of patients with HTLV-I uveitis. |
Q41403895 | In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors |
Q44771773 | In vitro transmission and antigenicity of a retrovirus isolated from a multiple sclerosis patient |
Q36231574 | In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II). |
Q37122656 | In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) |
Q39381418 | In vivo fluctuation of Tax, Foxp3, CTLA-4, and GITR mRNA expression in CD4(+)CD25(+) T cells of patients with human T-lymphotropic virus type 1-associated myelopathy |
Q39612164 | In vivo genomic footprinting of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat enhancer sequences in HTLV-1-infected human T-cell lines with different levels of Tax I activity |
Q36701505 | In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies |
Q39601697 | In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes |
Q39448054 | Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis |
Q39279168 | Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers |
Q39289897 | Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP. |
Q36859157 | Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis |
Q36399192 | Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies i |
Q39422572 | Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients |
Q37311248 | Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study |
Q24805302 | Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease |
Q37347687 | Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe? |
Q64097659 | Induction of APOBEC3B cytidine deaminase in HTLV-1-infected humanized mice |
Q35909704 | Induction of Cell Death in Growing Human T-Cells and Cell Survival in Resting Cells in Response to the Human T-Cell Leukemia Virus Type 1 Tax. |
Q33815891 | Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells. |
Q36635959 | Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization |
Q39433754 | Induction of cytokines in glial cells by trans activator of human T-cell lymphotropic virus type I |
Q45747449 | Induction of lymphocytic inflammatory changes in lung interstitium by human T lymphotropic virus type I. |
Q33905638 | Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells |
Q40671290 | Infection of the central nervous system by human retroviruses |
Q37536047 | Infectivity of chimeric human T-cell leukemia virus type I molecular clones assessed by naked DNA inoculation |
Q38864827 | Infectivity of human T-lymphotropic virus type I to human nervous tissue cells in vitro |
Q39097159 | Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection |
Q39421770 | Inflammatory lesions of peripheral nerve in a patient with human T-lymphotropic virus type I--associated myelopathy |
Q38262169 | Inflammatory manifestations of HTLV-1 and their therapeutic options |
Q45722152 | Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity |
Q44084238 | Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis |
Q42241090 | Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection |
Q59356083 | Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine |
Q39596759 | Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein. |
Q39207637 | Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes. |
Q35491663 | Inhibition of geranylgeranyl transferase-I decreases cell viability of HTLV-1-transformed cells |
Q35036496 | Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y. |
Q39576689 | Inhibition of human T-lymphotropic virus type I gene expression by the Streptomyces-derived substance EM2487. |
Q36424037 | Inhibition of methyltransferases results in induction of g2/m checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells |
Q34069424 | Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein |
Q36522664 | Inhibitory activity in saliva of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro: evaluation of saliva as an alternative source of transmission |
Q33843431 | Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis |
Q39550065 | Interaction of Gli2 with CREB protein on DNA elements in the long terminal repeat of human T-cell leukemia virus type 1 is responsible for transcriptional activation by tax protein |
Q45764767 | Interaction of human T-cell lymphotropic virus type I Tax, Ets1, and Sp1 in transactivation of the PTHrP P2 promoter |
Q36561858 | Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA |
Q33806783 | Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system |
Q39001989 | Interferon-alpha significantly reduces cerebrospinal fluid CD4 cell subsets in HAM/TSP. |
Q39138332 | Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells |
Q47763655 | Interleukin-10 gene expression and adult T-cell leukemia |
Q34192816 | Interleukin-13 overexpression by tax transactivation: a potential autocrine stimulus in human T-cell leukemia virus-infected lymphocytes |
Q39403386 | Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection |
Q39411009 | Interleukin-6 production in "normal" and HTLV-1 tax-expressing brain-specific endothelial cells |
Q36981737 | Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy |
Q47601290 | Interpretation of low reactivity in the Abbott Architect rHTLV I/II assay |
Q58691752 | Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for HTLV-1 associated myelopathy testing |
Q35833293 | Intrauterine transmission of human T-cell leukemia virus type I in rats |
Q40736260 | Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis |
Q41014732 | Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation |
Q39815291 | Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1. |
Q45751487 | Involvement of autoimmunity against type II collagen in the development of arthritis in mice transgenic for the human T cell leukemia virus type I tax gene |
Q35092867 | Is Sjögren's syndrome a retroviral disease? |
Q30913837 | Is human T cell lymphotropic type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) syndrome a neglected disease? |
Q35047215 | Isokinetic trunk and knee muscle strengths and gait performance in walking patients with T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP). |
Q28776767 | Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys |
Q39098426 | Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis |
Q24648442 | Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I |
Q38878558 | Juvenile human T lymphotropic virus type 1-associated myelopathy |
Q35229171 | Lack of association of Borna disease virus and human T-cell leukemia virus type 1 infections with psychiatric disorders among Japanese patients |
Q57830454 | Letters to the editors |
Q39579844 | Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens |
Q39173036 | Localization of retrovirus in the central nervous system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia |
Q36735681 | Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo |
Q39220045 | Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease? |
Q24658333 | Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection |
Q33932108 | Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations |
Q33650199 | Low prevalence of flower cells in U.S.A. blood donors infected with human T-lymphotrophic virus types I and II. |
Q45399118 | Low prevalence of human T cell lymphotropic virus type 1 infection in patients with gastric cancer. |
Q39512828 | Low-back pain in HTLV-I-associated myelopathy/tropical spastic paraparesis: nociceptive or neuropathic? |
Q39297216 | Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease. |
Q33622071 | Lupus nephritis class I accompanied by tubulointerstitial nephritis with marked T-lymphocyte infiltration in an HTLV-1 positive patient |
Q33590603 | MRI-pathological correlate of brain lesions in a necropsy case of HTLV-I associated myelopathy |
Q39563472 | Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL). |
Q42283356 | Mannose binding lectin and mannose binding lectin-associated serine protease-2 genes polymorphisms in human T-lymphotropic virus infection. |
Q36702147 | Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins |
Q33637013 | Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis |
Q54997268 | Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals |
Q26863681 | Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus |
Q38914690 | Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy |
Q37183161 | Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells |
Q57296147 | Metabolic abnormalities in adult T-cell leukemia/lymphoma and induction of specific leukemic cell death using photodynamic therapy |
Q40267356 | Methods for Identifying and Examining HTLV-1 HBZ Post-translational Modifications |
Q37067623 | MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes |
Q35812057 | Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease |
Q36099271 | Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein |
Q39611634 | Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy |
Q26752562 | Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission |
Q41724491 | Molecular and Cellular Mechanism of Leukemogenesis of ATL: Emergent Evidence of a Significant Role for HBZ in HTLV-1-Induced Pathogenesis |
Q42836979 | Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication |
Q38867574 | Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients |
Q37692056 | Molecular approach to human leukemia: isolation and characterization of the first human retrovirus HTLV-1 and its impact on tumorigenesis in adult T-cell leukemia |
Q30698124 | Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). |
Q37648645 | Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia |
Q36690145 | Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals |
Q35136041 | Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technology |
Q36958543 | Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax |
Q33575495 | Molecular cloning of human T-cell lymphotrophic virus type I-like proviral genome from the peripheral lymphocyte DNA of a patient with chronic neurologic disorders |
Q39443979 | Molecular detection and isolation of human T-cell lymphotropic virus type I (HTLV-I) from patients with HAM/TSP in São Paulo, Brazil. |
Q35261463 | Molecular determinants of human T-lymphotropic virus type 1 transmission and spread |
Q92016839 | Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes |
Q40804672 | Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. |
Q34450092 | Molecular mechanisms of cellular transformation by HTLV-1 Tax. |
Q41035613 | Molecular mechanisms of promoter regulation of the gp34 gene that is trans-activated by an oncoprotein Tax of human T cell leukemia virus type I. |
Q45764235 | Molecular phylogeny of human T-cell leukemia virus type I and II of Amerindians in Colombia and Chile |
Q39014284 | Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease |
Q50604367 | Mortality among inhabitants of an HTLV-I endemic area in Japan. |
Q36419884 | Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau |
Q55243202 | Mother-to-child transmission in HTLV-I associated myelopathy. |
Q39496391 | Motor and somatosensory evoked potential findings in HTLV-I associated myelopathy |
Q35138158 | Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma |
Q39581878 | Multimer formation is not essential for nuclear export of human T-cell leukemia virus type 1 Rex trans-activator protein |
Q33631253 | Multimodality evoked potentials in HTLV-I associated myelopathy |
Q33933008 | Multiple isolates and characteristics of human T-cell leukemia virus type II |
Q57224696 | Multiple sclerosis (not tropical spastic paraparesis) on Key West, Florida |
Q55239594 | Multiplex PCR using real time DNA amplification for the rapid detection and quantitation of HTLV I or II. |
Q38546539 | Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention |
Q38327790 | Multistep regulation of enhancer activity of the 21-base-pair element of human T-cell leukemia virus type I |
Q35575009 | Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection |
Q39042631 | Muscle MRI findings of HTLV-1-associated myelopathy |
Q36687133 | Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant proteins |
Q41236165 | Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation? |
Q42091359 | Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression |
Q45435678 | Mycosis fungoides in European Russia: no antibodies to human T cell leukemia virus type I structural proteins, but virus-like sequences in blood and saliva. |
Q35218631 | Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB |
Q43837693 | N-Terminal domain of HTLV-I integrase. Complexation and conformational studies of the zinc finger |
Q39869820 | Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. |
Q55243194 | Necropsy findings in HTLV-I associated myelopathy. |
Q39543309 | Neuro-otologic abnormalities in myelopathy associated with human T-cell lymphotropic virus type 1. |
Q37741036 | Neuroimmunity of HTLV-I Infection |
Q38128799 | Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis |
Q64093299 | Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis |
Q43497442 | Neurologic manifestations related to HTLV-1 viruses |
Q35975547 | Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study |
Q39169639 | Neurological manifestations in HTLV-I-infected blood donors |
Q35475478 | Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls |
Q30803056 | New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones |
Q37435359 | No Evidence of HTLV-II Infection Among Immonoblot Indeterminate Samples Using Nested PCR in Mashhad, Northeast of Iran |
Q55242153 | No evidence of HTLV-1 infection in Japanese multiple sclerosis patients in polymerase chain reaction. |
Q39435039 | No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand |
Q92381563 | Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle |
Q39308343 | Novel complications with HTLV-1-associated myelopathy/tropical spastic paraparesis: interstitial cystitis and persistent prostatitis |
Q45788568 | Nucleotide Sequence and Restriction Fragment Length Polymorphism Analysis of the Long Terminal Repeat of Human T Cell Leukemia Virus Type II |
Q38898730 | Nucleotide sequence analysis of human T-cell lymphotropic virus type I pX and LTR regions from patients with sicca syndrome |
Q39385699 | Ocular lesions in HTLV-1 infected patients from Salvador, State of Bahia: the city with the highest prevalence of this infection in Brazil |
Q44956108 | Ocular manifestations of adult T-cell leukemia/lymphoma. A clinicopathologic study |
Q33719211 | On the etiology of tropical spastic paraparesis and human T-cell lymphotropic virus-I-associated myelopathy |
Q38958917 | Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia |
Q40332680 | Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene |
Q26741360 | P-TEFb goes viral |
Q38896947 | P-TEFb goes viral. |
Q33960604 | PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner |
Q35854542 | PCR-in situ hybridization detection of human T-cell lymphotropic virus type 1 (HTLV-1) tax proviral DNA in peripheral blood lymphocytes of patients with HTLV-1-associated neurologic disease |
Q41895077 | PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo |
Q38934680 | Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients |
Q37547042 | Palmitoylation and p8-mediated human T-cell leukemia virus type 1 transmission |
Q33589322 | Pathogenesis and treatment of HTLV-I associated myelopathy |
Q39445928 | Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State. |
Q40874333 | Pathogenesis of virus-induced demyelination. |
Q92489483 | Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease |
Q34981289 | Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). |
Q36343823 | Pathways of cell-cell transmission of HTLV-1 |
Q40357307 | Pattern-reversal visual evoked potentials in patients with human T-lymphotropic virus type 1 uveitis |
Q39321233 | Patterns of in vitro lymphoproliferative responses among HTLV-1-infected subjects: upregulation by HTLV-1 during HIV-1 co-infection. |
Q45728415 | Performance certification of gelatin particle agglutination assay for anti-HTLV-1 antibody: inconclusive positive results |
Q59352347 | Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil |
Q70249315 | Peripheral T-cell lymphoma |
Q34601530 | Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens |
Q39169634 | Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy |
Q40103935 | Perturbation of Human T-Cell Leukemia Virus Type 1 Particle Morphology by Differential Gag Co-Packaging. |
Q35576980 | Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I |
Q36650699 | Phorbol esters modulate the phosphorylation of human T-cell leukemia virus type I Tax |
Q33783321 | Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells |
Q36632768 | Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission |
Q34349249 | Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background |
Q36685919 | Phylogeography of Human T-lymphotropic Virus Type 1 (HTLV-1) Lineages Endemic to Japan |
Q36957291 | Physical and in silico approaches identify DNA-PK in a Tax DNA-damage response interactome |
Q45087228 | Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy |
Q38700350 | Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed through Characterization of a Chronically Infected Cell Line |
Q45397641 | Polymorphism in the promoter region of the mannose-binding lectin gene among human T-cell lymphotropic virus infected subjects. |
Q46255945 | Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects |
Q38874995 | Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy |
Q41695126 | Possible association between adult T-cell leukemia/lymphoma and acute myeloid leukemia |
Q39293022 | Post-mortem diagnosis of human T lymphotrophic virus type-1 (HTLV-1) associated myelopathy by detection of HTLV-1 DNA in the spinal cord of a patient with post-transfusional myelopathy |
Q35475269 | Post-transplantation HTLV-1 myelopathy in three recipients from a single donor |
Q43878038 | Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1. |
Q39124766 | Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy |
Q39611439 | Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis). |
Q48047487 | Prevalence and phylogenetic analysis of HTLV-I isolates in Cameroon, including those of the Baka Pygmy |
Q39269319 | Prevalence of HTLV-1 antibodies in hemodialysis patients in Japan |
Q55240710 | Prevalence of HTLV-I-associated uveitis in the Kanto Plain, Japan. |
Q47106331 | Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil |
Q43656509 | Prevalence of antibodies to HTLV-1 in South American Indians (Mapuches) from Chile |
Q33838100 | Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder |
Q38894583 | Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile. |
Q38675283 | Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status |
Q39517698 | Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. |
Q37125891 | Primary isolation of human T-cell leukemia-lymphoma virus types I and II: use for confirming infection in seroindeterminate blood donors |
Q41749317 | Production of tumor necrosis factors by human T cell lines infected with HTLV-1 may cause their high susceptibility to human immunodeficiency virus infection |
Q55239494 | Prognosis of HTLV-I-positive renal transplant recipients. |
Q41142042 | Progressive necrotic myelopathy as a paraneoplastic syndrome: report of a case and some pathogenetic considerations |
Q35635312 | Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells. |
Q36642754 | Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. |
Q39826162 | Propensity for HBZ-SP1 isoform of HTLV-I to inhibit c-Jun activity correlates with sequestration of c-Jun into nuclear bodies rather than inhibition of its DNA-binding activity |
Q55240314 | Prophylaxis of experimental HTLV-I infection in cynomolgus monkeys by passive immunization. |
Q59354917 | Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity |
Q41927250 | Prosultiamine for treatment of lower urinary tract dysfunction accompanied by human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis |
Q38294744 | Protein domains involved in both in vivo and in vitro interactions between human T-cell leukemia virus type I tax and CREB. |
Q37210537 | Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I |
Q41115170 | Protein-glycosaminoglycan interactions: infectiological aspects |
Q38906684 | Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru |
Q37466795 | Proviral loads and clonal expansion of HTLV-1-infected cells following vertical transmission: a 10-year follow-up of children in Jamaica |
Q45364790 | Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes |
Q39528047 | Provirus expansion and deregulation of apoptosis-related genes in the spinal cord of a rat model for human T-lymphocyte virus type I-associated myeloneuropathy |
Q45754312 | Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activities |
Q35643970 | Psychiatric Disorders in HTLV-1-Infected Individuals with Bladder Symptoms |
Q44853801 | Purification and characterization of human T-cell leukemia virus type I protease produced in Escherichia coli |
Q39219928 | Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis |
Q40985236 | Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction |
Q38968633 | Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay |
Q35891629 | Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica |
Q35752816 | Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-Myb |
Q41630410 | Rapid, sensitive, specific, and quantitative detection of human T-cell leukemia virus type 1 sequence in peripheral blood mononuclear cells by an improved polymerase chain reaction method with nested primers |
Q28564663 | Rat CRM1 is responsible for the poor activity of human T-cell leukemia virus type 1 Rex protein in rat cells |
Q35604172 | Recombinant human T-cell leukemia virus types 1 and 2 Tax proteins induce high levels of CC-chemokines and downregulate CCR5 in human peripheral blood mononuclear cells |
Q35833427 | Recombination between feline exogenous and endogenous retroviral sequences generates tropism for cerebral endothelial cells. |
Q45428250 | Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1. |
Q43904336 | Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. |
Q44532346 | Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. |
Q35023802 | Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells |
Q35832730 | Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren's syndrome. |
Q33956264 | Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity. |
Q42267362 | Relevance of molecular tests for HTLV-1 infection as confirmatory tests after the first sero-screening |
Q40303602 | Relevance of retrovirus quantification in cerebrospinal fluid for neurologic diagnosis |
Q37568028 | Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator |
Q37093004 | Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model |
Q45865682 | Requirement of N- and C-terminal regions for enzymatic activity of human T-cell leukemia virus type I protease |
Q36380309 | Resistance to fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy |
Q35879289 | Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection |
Q33649071 | Retinal vasculitis in a mother and her son with human T-lymphotropic virus type 1 associated myelopathy |
Q39534459 | Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). |
Q26853678 | Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research |
Q34895177 | Retroviral proteins that target the major histocompatibility complex class I. |
Q36868753 | Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease |
Q69953799 | Retrovirus-associated adult T-cell leukemia-lymphoma: an epidemiologic study of five cases among Hawaii-born offspring of migrant Japanese |
Q28769657 | Retroviruses and human disease |
Q40062672 | Rex transregulation of human T-cell leukemia virus type II gene expression. |
Q34572250 | Rheumatoid arthritis and tumor necrosis factor alpha |
Q37773234 | Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer |
Q47201640 | Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP. |
Q92091882 | Role of HTLV-1 orf-I encoded proteins in viral transmission and persistence |
Q55239807 | Role of HTLV-I infection in the pathogenesis of Sjögren's syndrome and rheumatoid arthritis. |
Q38025392 | Role of Nucleocytoplasmic RNA Transport during the Life Cycle of Retroviruses |
Q36699176 | Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture |
Q39255955 | Role of neuronal interferon-gamma in the development of myelopathy in rats infected with human T-cell leukemia virus type 1. |
Q45150040 | Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL). |
Q34306720 | Role of viruses in etiology and pathogenesis of multiple sclerosis |
Q24310639 | SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily |
Q57061692 | STLV-1 co-infection is correlated with an increased SFV proviral load in the peripheral blood of SFV/STLV-1 naturally infected non-human primates |
Q38859934 | SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness. |
Q37430929 | Safety of blood transfusion: the Japanese experience |
Q33769730 | Screening of blood donations for HTLV-I/II. |
Q39318432 | Search for human T-cell leukemia virus type I (HTLV-I) proviral sequences by polymerase chain reaction in the central nervous system tissue of HTLV-I-associated myelopathy |
Q45753713 | Search for human T-lymphotropic virus type I carriers among northeastern Chinese |
Q37106216 | Search for retrovirus in the chronic fatigue syndrome |
Q34273466 | Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. |
Q39149912 | Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient |
Q39216604 | Sequence analysis of human T cell lymphotropic virus type I (HTLV-I) Env genes amplified from central nervous system tissues of patients with HTLV-I-associated myelopathy or leukemia |
Q38889863 | Sequence and phylogenetic analysis of human T cell lymphotropic virus type 1 from Tumaco, Colombia |
Q36504681 | Seroepidemiology of HTLV-I in relation to that of HIV-1 in the Gauteng region, South Africa, using dried blood spots on filter papers |
Q45373744 | Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile |
Q30847345 | Seroprevalence of human T-lymphotropic virus type 1 in Papua New Guinea and Irian Jaya measured using different western blot criteria |
Q39332420 | Severe demyelinating myelopathy with low human T cell lymphotropic virus type 1 expression after transfusion in an immunosuppressed patient |
Q37381691 | Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders. |
Q37397113 | Sexual transmission of human T-cell leukemia virus type I associated with the presence of anti-Tax antibody |
Q54783970 | Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. |
Q44406750 | Significance of Human T-Lymphotropic Virus Type I Indeterminant Serological Findings among Healthy Individuals |
Q94523255 | Signs, meanings and practices of people living with human t-cell lymphotropic virus type 1 or tropical spastic myelopathy |
Q34280854 | Simian T-cell lymphotropic Viruses (STLVs) and lymphomas in African nonhuman primates |
Q41381866 | Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines |
Q38911642 | Six Colombian patients with adult T-cell leukemia/lymphoma |
Q33777159 | Soluble IL-2 receptor and beta-2 microglobulin as possible serologic markers of neurologic disease in HTLV-1 infection |
Q41197300 | Sp1 family proteins recognize the U5 repressive element of the long terminal repeat of human T cell leukemia virus type I through binding to the CACCC core motif |
Q35743020 | Specific interaction of HTLV tax protein and a human type IV neuronal intermediate filament protein |
Q58700496 | Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1) |
Q55239412 | Spontaneous cell proliferation is associated with poor sensitivity to glucocorticoids in patients infected with HTLV. |
Q49433316 | Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5. |
Q45751051 | Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase |
Q39138338 | Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon |
Q40062240 | Strong trans activation of the human cytomegalovirus major immediate-early enhancer by p40tax of human T-cell leukemia virus type I via two repetitive tax-responsive sequence elements |
Q33617251 | Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area. |
Q45412079 | Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus |
Q55015262 | Subtype analysis of HTLV-1 in patients with HTLV-1 uveitis. |
Q51618022 | Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation. |
Q41757038 | Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I). |
Q41195203 | Survey of anti-human T-cell leukemia virus type I antibody in family members of patients with adult T-cell leukemia |
Q40876611 | Synthesis and CD studies of an 88-residue peptide containing the main receptor binding site of HTLV-I SU-glycoprotein |
Q24650854 | T helper cell activation and human retroviral pathogenesis |
Q35611762 | T-cell control by human T-cell leukemia/lymphoma virus type 1. |
Q55242740 | T-lymphocyte alveolitis in HTLV-I-associated myelopathy. |
Q92154419 | TREX1 531C>T Polymorphism is Associated with High Proviral Load Levels in HTLV-1-Infected Persons |
Q39119691 | Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells |
Q39147176 | Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. |
Q33826936 | Tax 1-independent induction of vascular endothelial growth factor in adult T-cell leukemia caused by human T-cell leukemia virus type 1. |
Q35139310 | Tax abolishes histone H1 repression of p300 acetyltransferase activity at the human T-cell leukemia virus type 1 promoter |
Q34647848 | Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription |
Q35838179 | Tax mutation associated with tropical spastic paraparesis/human T-cell leukemia virus type I-associated myelopathy |
Q35184274 | Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation |
Q40553944 | Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells |
Q47107838 | The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis |
Q34562309 | The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I |
Q39606189 | The NH2-terminal domain of the human T-cell leukemia virus type 1 capsid protein is involved in particle formation |
Q42720021 | The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease |
Q26768630 | The Role of HBZ in HTLV-1-Induced Oncogenesis |
Q34760052 | The Sonoda-Tajima Cell Collection: a human genetics research resource with emphasis on South American indigenous populations |
Q36173231 | The Tax-Inducible Actin-Bundling Protein Fascin Is Crucial for Release and Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (HTLV-1). |
Q24301990 | The bZIP transcription factor ATFx binds human T-cell leukemia virus type 1 (HTLV-1) Tax and represses HTLV-1 long terminal repeat-mediated transcription |
Q39139939 | The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy |
Q59354934 | The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (all |
Q37686085 | The contribution of Asian researchers to the field of rheumatology |
Q34199889 | The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients |
Q38789112 | The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines |
Q35894677 | The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events. |
Q39512097 | The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis |
Q39055611 | The effect of rolipram on the production of cytokines in HTLV-I infected cell lines and peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy (HAM). |
Q37253315 | The epidemiology of HTLV-I infection |
Q36315236 | The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation |
Q39582339 | The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein. |
Q35077555 | The human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasome |
Q35882436 | The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins |
Q35861241 | The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface |
Q36655687 | The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. |
Q35874668 | The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex |
Q37673010 | The motor evoked potential in AIDS and HAM/TSP: state of the evidence |
Q36829681 | The oncoprotein Tax of the human T-cell leukemia virus type 1 activates transcription via interaction with cellular ATF-1/CREB factors in Saccharomyces cerevisiae. |
Q40861471 | The origin and evolution of human T-cell lymphotropic virus types I and II. |
Q36687002 | The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. |
Q33934512 | The pathogenesis of the neurological complications of HIV-1 infection. |
Q41137663 | The pathology of the chronic lymphoid leukaemias |
Q45772835 | The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea |
Q37192205 | The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2. |
Q39206753 | The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis |
Q42047960 | The role of the thymus in development of necrotizing arteritis in transgenic rats carrying the env-pX gene of human T-cell leukemia virus type-I. |
Q39119670 | The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases |
Q50941409 | The seroprevalence of HTLV-I in patients with ocular diseases, pregnant women and healthy volunteers in the Kanto district, central Japan. |
Q35883025 | The simian T-lymphotropic/leukemia virus from Pan paniscus belongs to the type 2 family and infects Asian macaques. |
Q36063657 | The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. |
Q42204031 | The transcription elongation factor ELL2 is specifically upregulated in HTLV-1-infected T-cells and is dependent on the viral oncoprotein Tax. |
Q34387588 | The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties |
Q37952807 | The tug-of-war between dendritic cells and human chronic viruses |
Q37541300 | The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements |
Q28184983 | The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV |
Q36813399 | Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice |
Q35848268 | Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay. |
Q54204709 | Time to eradicate HTLV-1: an open letter to WHO. |
Q45788217 | Transactivation of human T-cell leukemia virus type 1 by herpes simplex virus type 1 |
Q33676408 | Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy |
Q41655886 | Transactivation of the interleukin-1 alpha promoter by human T-cell leukemia virus |
Q36814951 | Transactivation of the proenkephalin gene promoter by the Tax1 protein of human T-cell lymphotropic virus type I |
Q33938049 | Transcription factor AP-2 activates gene expression of HTLV-I |
Q42280405 | Transcriptional activation of the interleukin-21 gene and its receptor gene by human T-cell leukemia virus type 1 Tax in human T-cells |
Q35898564 | Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein. |
Q39095920 | Transduction of dominant negative ATF-1 suppresses the pX gene expression in joint fibroblastic cells derived from HTLV-I transgenic rats |
Q41658470 | Transformation of CD8+ T-cells producing a strong cytopathic effect on CD4+ T-cells through syncytium formation by HTLV-II. |
Q40065035 | Transgenic thymocytes are refractory to transformation by the human T-cell leukemia virus type I tax gene |
Q40623668 | Transition of adult T-cell leukemia/lymphoma clones during clinical progression. |
Q39252619 | Transmission of human T-cell leukemia virus type I from a patient with HTLV-I associated myelopathy/tropical spastic paraparesis and an asymptomatic carrier to rabbits |
Q30797529 | Transmission of human T-cell lymphotropic virus type 1 tax to rabbits by tax-only-positive human cells |
Q46577818 | Treatment for HTLV-I associated arthropathy: a case study and synovial tissue culture analysis |
Q28972318 | Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy |
Q39153035 | Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin |
Q33566077 | Treatment of patients with polyarthritis and anti-HTLV-I antibodies with interferon-alpha |
Q45739072 | Trends in the seroprevalence of HTLV-1 in Japanese blood donors in Nagasaki Prefecture, 2000-2006. |
Q39049948 | Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM): Treatment with an Anabolic Steroid Danazol |
Q69903357 | Tropical spastic paraparesis |
Q39029919 | Tropical spastic paraparesis and HTLV-I infection: clinical and epidemiological study in Lima, Peru |
Q39403720 | Tropical spastic paraparesis/HTLV-I associated myelopathy. Etiology and clinical spectrum |
Q55240599 | Tropical spastic paraparesis: a necessary redefinition |
Q39877808 | Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells. |
Q36132707 | Tumor immunity against adult T-cell leukemia |
Q45832827 | Two major subgroups of human T-cell leukemia virus-1 in Japan |
Q33835940 | Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus) |
Q42200235 | Ultrasonography and magnetic resonance imaging findings of rheumatoid arthritis-like arthritis in a patient with adult T-cell leukemia |
Q39178769 | Ultrastructural pathology of a Chilean case of tropical spastic paraparesis/human T-cell lymphotropic type I-associated myelopathy (TSP/HAM). |
Q40086144 | Up-regulation of hepatitis C virus replication by human T cell leukemia virus type I-encoded Tax protein |
Q41074323 | Up-regulation of iNOS mRNA expression and increased production of NO in human monoblast cell line, U937 transfected by HTLV-I tax gene. |
Q39013619 | Up-regulation of interleukin-12 receptor expression in peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis |
Q37099844 | Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein |
Q38934616 | Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals |
Q37268551 | Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes. |
Q39608040 | Use of transgenic animals to study human retroviruses |
Q39506433 | Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis |
Q60919995 | Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii |
Q44032350 | Vertical transmission of HTLV-1 in HTLV-1 carrier rat. |
Q47571734 | Viral Oncology: Molecular Biology and Pathogenesis |
Q35835490 | Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells. |
Q38100771 | Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1. |
Q33768325 | Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease |
Q55242998 | Viruses detected in HTLV-I-associated myelopathy and adult T-cell leukaemia are identical on DNA blotting. |
Q40475828 | Viruses, virulence and pathogenicity. |
Q35107212 | Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis |
Q45843250 | Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM). |
Q36540100 | XBP-1, a novel human T-lymphotropic virus type 1 (HTLV-1) tax binding protein, activates HTLV-1 basal and tax-activated transcription |
Q35065987 | Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial |
Q55239247 | [Combined infection with HTLV-1 and Strongyloides stercoralis]. |
Q55239509 | [Dermatologic lesions in patients infected with the human T-cell lymphotropic virus type 1 (HTLV-1)]. |
Q55239400 | [Evaluation of the performance of immunological parameters as indicators for clinical progression of chronic HTLV-1 infection]. |
Q55239276 | [HTLV-1 associated myelopathy: clinical and epidemiological profile in a 10-year case series study]. |
Q55240236 | [HTLV-I-associated myelopathy, tropical spastic paraparesis: report of the first cases in Sergipe, Brazil] |
Q55239557 | [Infective dermatitis and recurrent strongyloidiasis in a child] |
Q55239553 | [Seroprevalence of human T cell lymphotropic virus infection and associated factors of risk in blood donors of Rio Branco city, AC, Brazil (1998-2001)]. |
Q55239399 | [Sociodemographic, epidemiological and behavioral profile of women infected with HTLV-1 in Salvador, Bahia, an endemic area for HTLV]. |
Q55241130 | [Tropical spastic paraparesis in the tropics and Brazil. A historical analysis] |
Q39879902 | cis-Acting inhibitory elements within the pol-env region of human T-cell leukemia virus type 1 possibly involved in viral persistence |
Q40409057 | p21X mRNA is expressed as a singly spliced pX transcript from defective provirus genomes having a partial deletion of the pol-env region in human T-cell leukemia virus type 1-infected cells |
Q36794695 | trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene |
Q36732129 | trans activation of nerve growth factor in transgenic mice containing the human T-cell lymphotropic virus type I tax gene |
Search more.